The Medical Council of India has approved a draft notification which makes it mandatory for doctors to write the prescription in capital letters to avoid illegibility amid complaints that chemists sometimes give wrong medicines because of similar sounding names of drugs.
The draft notification will come into effect after its approval by the Health Ministry, official sources said.
They said the Health Ministry is inclined to implement the idea.
Once the decision is taken, directions will be issued to doctors nationwide to follow the new rule.
Some of the similar sounding medicines include -- Celin (vitamin C) and Celib (celecoxib, for arthritis), Malaquin (chloroquine, an anti-malarial drug) and Mahaquin (lomefloxacin, an antibiotic) and Azoo (azithromycin, an antibiotic) and Azox (alprazolam, an anti-anxiety drug).
"We have been confronted with this problem for years.... The idea is good and we will have to look at all aspects," an official source said.
However, the sources said that doctors are not comfortable with this idea.
A sense of urgency has been injected by the rising number of complaints from patients as well industry about the illegibility of prescriptions and how patients at times end up consuming wrong medicines which could have harmful impact on them as well.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
